Friday, May 1, 2026

Is A Breakthrough For Thyroid Eye Disease Still Out Of Reach?

HanAll Biopharma's Phase 3 trial of batoclimab for Thyroid Eye Disease failed to show statistical significance, but safety profiles remain consistent.

As Wegovy and Mounjaro Soar, Korean Biotechs Seek a Slice of the Obesity Drug Market

South Korean firms are innovating in the GLP-1 obesity treatment market, developing unique drugs to compete with industry leaders.

GreenVet Announces CaniCancer-FFPE, a Precision Cancer Diagnostic Solution for Pets

GreenVet introduces CaniCancer, a unified cancer diagnostic solution for pets, streamlining biopsy and genetic testing for faster treatment.

Tag: Donghae Line

No posts to display

Top News

North Korea Utilizing Russian Troops Deployed for Sacrifice Solely as Propaganda...

Yeo Ik Lim - December 15, 2025

North Korea held a grand ceremony for its 528th Engineer Regiment, honoring fallen soldiers and using their sacrifice for state propaganda.

EU Stock Markets Plummet: What’s Behind the 25% Tariff Threat from...

January 20, 2026

Will Ju Ae Take Over? Insights into North Korea’s Future Leadership...

December 26, 2025

How Lunit’s AI is Transforming Early Breast Cancer Risk Assessment: Key...

March 5, 2026

Tariffs Bite: Korean Auto and Petrochemical Giants Post Sharp Q2 Declines

September 11, 2025

ST Pharm Secures Key mRNA-LNP Patent STP1244 in Japan

April 13, 2026

Exploring North Korea’s New Constitutional Changes: Will Two States Become Law?

March 18, 2026

OpenAI’s Pioneer Program Aims to Reinvent AI Evaluation Standards

April 10, 2025

- Our Sponsors Ad -